SINCO PHARMA (06833)
| Auditor | From | To | Release Date / Document Links | Reason for Change |
|---|---|---|---|---|
| Cl Partners Cpa | 13-Dec-22 | |||
| Ernst & Young | 20-Jul-20 | 08-Dec-22 | Could not come to a consensus in relation to the timeline for the preparation of the audit work for the Company’s annual results for the year ended 31 December 2022. The Company was informed by EY that they could only commence the Audit after the completion of the Forensic Investigation. |